首页 | 本学科首页   官方微博 | 高级检索  
     

尿激酶静脉溶栓治疗急性心肌梗死38例临床分析
引用本文:陈吉汉. 尿激酶静脉溶栓治疗急性心肌梗死38例临床分析[J]. 中国煤炭工业医学杂志, 2011, 14(7): 975-976
作者姓名:陈吉汉
作者单位:淮南朝阳医院心内科,安徽省淮南市,232007
摘    要:
目的探讨尿激酶静脉溶栓治疗急性心肌梗死的临床疗效及安全性。方法分析2006年2月—2011年2月收住我科的38例急性心肌梗死患者的临床资料。结果本组冠脉再通29例,再通率76.3%;6例(15.8%)发生轻微出血并发症。结论尿激酶静脉溶栓治疗可靠、安全、使用方便、并发症发生率低且轻微。

关 键 词:尿激酶  静脉溶栓  急性心肌梗死

CLINICAL OBSERVATION OF INTRAVENOUS THROMBOLYSIS WITH UROKINASE IN TREATING 38 CASES WITH ACUTE MYOCARDIAL INFARCTION
Chen Jihan. CLINICAL OBSERVATION OF INTRAVENOUS THROMBOLYSIS WITH UROKINASE IN TREATING 38 CASES WITH ACUTE MYOCARDIAL INFARCTION[J]. Chinese Journal of Coal Industry Medicine, 2011, 14(7): 975-976
Authors:Chen Jihan
Affiliation:Chen Jihan.Department of Cardiology,Anhui Huainan Chaoyang Hospital,Huainan 232007,China
Abstract:
Objective To investigate the clinical efficacy and safety of the urokinase intravenous thrombolytic in the treatment of acute myocardial infarction.Methods The clinical data of 38 cases of AMI patients were collected and analyzed in our department of cardiology from 2006 to 2011.Results 29 cases of AMI patients artery were recanalized,the successful rates were 76.3%,6 cases(15.8%) have slightly bloody complication.Conclusion Thrombolytic therapy with urokinase in patients of acute myocardial infarction can ...
Keywords:urokinase  intravenous thrombolysis  acute myocardial infarction  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号